• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bullous Central Serous Chorioretinopathy Associated With JAK Inhibitor Use.与使用JAK抑制剂相关的大疱性中心性浆液性脉络膜视网膜病变
J Vitreoretin Dis. 2025 Apr 25:24741264251337104. doi: 10.1177/24741264251337104.
2
Management of Atypical Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease.疑似Vogt-小柳-原田病的非典型中心性浆液性脉络膜视网膜病变的管理
J Vitreoretin Dis. 2023 Feb 17;7(3):249-253. doi: 10.1177/24741264231152675. eCollection 2023 May-Jun.
3
Scleral thinning surgery for bullous retinal detachment with retinal pigment epithelial tear in central serous chorioretinopathy: a case report.巩膜变薄手术治疗中心性浆液性脉络膜视网膜病变伴视网膜色素上皮撕裂的大泡性视网膜脱离:病例报告。
BMC Ophthalmol. 2020 Apr 6;20(1):133. doi: 10.1186/s12886-020-01409-w.
4
Bullous central serous chorioretinopathy and retinal pigment epithelium sequelae postblunt trauma.钝挫伤后大疱性中心性浆液性脉络膜视网膜病变及视网膜色素上皮后遗症。
BMJ Case Rep. 2020 Sep 23;13(9):e235882. doi: 10.1136/bcr-2020-235882.
5
Central Serous Chorioretinopathy: Morphological and Functional Outcome after Subthreshold Thermal Laser Coagulation with a Frequency-Doubled Nd:YAG Continuous-Wave Laser.中心性浆液性脉络膜视网膜病变:倍频 Nd:YAG 连续波激光阈下热激光光凝术后的形态学和功能结果。
Ophthalmologica. 2022;245(1):59-68. doi: 10.1159/000519234. Epub 2021 Sep 13.
6
Central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变
Optometry. 2008 May;79(5):241-51. doi: 10.1016/j.optm.2007.02.024.
7
Surgical Treatment of Bullous Exudative Retinal Detachment Secondary to Atypical Bilateral Central Serous Chorioretinopathy.手术治疗非典型双侧中心性浆液性脉络膜视网膜病变继发的大疱性渗出性视网膜脱离。
Turk J Ophthalmol. 2023 Dec 21;53(6):395-398. doi: 10.4274/tjo.galenos.2023.75233. Epub 2023 Nov 28.
8
The tipping point: Tamoxifen toxicity, central serous chorioretinopathy, and the role of estrogen and its receptors.临界点:他莫昔芬毒性、中心性浆液性脉络膜视网膜病变以及雌激素及其受体的作用
Am J Ophthalmol Case Rep. 2016 May 18;3:8-13. doi: 10.1016/j.ajoc.2016.05.004. eCollection 2016 Oct.
9
Uncommon Therapeutic Approaches for Patients with Recurrent Central Serous Chorioretinopathy: case report and literature review.复发性中心性浆液性脉络膜视网膜病变患者的罕见治疗方法:病例报告与文献综述
Rom J Ophthalmol. 2025 Jan-Mar;69(1):17-21. doi: 10.22336/rjo.2025.04.
10
Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone - a case report.米诺地尔引起的中心性浆液性脉络膜视网膜病变经口服依普利酮治疗——一例报告。
BMC Ophthalmol. 2020 Jun 5;20(1):219. doi: 10.1186/s12886-020-01499-6.

本文引用的文献

1
Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone.采用光动力疗法(PDT)和依普利酮治疗双侧大疱性中心性浆液性脉络膜视网膜病变。
Am J Ophthalmol Case Rep. 2022 Nov 2;28:101739. doi: 10.1016/j.ajoc.2022.101739. eCollection 2022 Dec.
2
Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies.乌帕替尼治疗中重度特应性皮炎的安全性:3 期研究的综合分析。
J Allergy Clin Immunol. 2023 Jan;151(1):172-181. doi: 10.1016/j.jaci.2022.09.023. Epub 2022 Oct 1.
3
Pathogenic Risk Factors and Associated Outcomes in the Bullous Variant of Central Serous Chorioretinopathy.大疱性中心性浆液性脉络膜视网膜病变的致病危险因素及相关转归。
Ophthalmol Retina. 2022 Oct;6(10):939-948. doi: 10.1016/j.oret.2022.04.015. Epub 2022 Apr 25.
4
Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review.与类风湿关节炎相关的 Janus 激酶抑制剂的静脉血栓栓塞风险:病例报告和文献复习。
Clin Rheumatol. 2021 Nov;40(11):4457-4471. doi: 10.1007/s10067-021-05911-4. Epub 2021 Sep 23.
5
Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?Janus 激酶(JAK)抑制剂的血栓栓塞性药物不良反应:抑制剂的特异性是否起作用?
Int J Mol Sci. 2021 Feb 28;22(5):2449. doi: 10.3390/ijms22052449.
6
Pachychoroid disease.脉络膜增厚性疾病。
Eye (Lond). 2019 Jan;33(1):14-33. doi: 10.1038/s41433-018-0158-4. Epub 2018 Jul 11.
7
Atypical Central Serous Chorioretinopathy.非典型中心性浆液性脉络膜视网膜病变
Turk J Ophthalmol. 2017 Aug;47(4):238-242. doi: 10.4274/tjo.38039. Epub 2017 Aug 15.
8
Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging.大疱性中心性浆液性脉络膜视网膜病变:多模态成像对表型特征的扩展研究。
Ophthalmology. 2016 Jul;123(7):1541-52. doi: 10.1016/j.ophtha.2016.03.017. Epub 2016 Apr 12.
9
Bullous variant of idiopathic central serous chorioretinopathy.特发性中心性浆液性脉络膜视网膜病变的大疱性变体
Br J Ophthalmol. 2000 May;84(5):485-92. doi: 10.1136/bjo.84.5.485.
10
Bullous retinal detachment. An unusual manifestation of idiopathic central serous choroidopathy.大泡性视网膜脱离。特发性中心性浆液性脉络膜视网膜病变的一种不寻常表现。
Am J Ophthalmol. 1973 May;75(5):810-21. doi: 10.1016/0002-9394(73)90887-8.

与使用JAK抑制剂相关的大疱性中心性浆液性脉络膜视网膜病变

Bullous Central Serous Chorioretinopathy Associated With JAK Inhibitor Use.

作者信息

Apel Warren, Li Ye

机构信息

Department of Ophthalmology, Sunshine Coast University Hospital, QLD, Australia.

出版信息

J Vitreoretin Dis. 2025 Apr 25:24741264251337104. doi: 10.1177/24741264251337104.

DOI:10.1177/24741264251337104
PMID:40291492
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12031730/
Abstract

To report a case of bullous central serous chorioretinopathy (CSCR) after starting a Janus kinase (JAK) inhibitor and describe the results of focal laser treatment. A single case was evaluated. A 54-year-old man with rheumatoid arthritis presented with a 2-week history of left superior field loss. His medications included prednisone 10 mg and upadacitinib, which was added to his regimen 3 weeks previously. His visual acuity (VA) was 20/25 OD and 20/30 OS. An ophthalmic examination of the left eye found an ill-defined white lesion of 2 × 3 disc diameters at the macula with an inferior retinal detachment (RD). Optical coherence tomography showed subretinal fibrin with subretinal fluid (SRF) and a pigment epithelial detachment. After a diagnosis of bullous CSCR was made, focal laser application was performed. One year later, the patient's VA recovered to 20/20 with resolved SRF. Bullous CSCR with a serous RD is an uncommon subtype of pachychoroid disease. Upadacitinib may be associated with its occurrence through disequilibrium of the coagulation cascade. Focal laser treatment offers a favorable outcome for this disease.

摘要

报告一例在开始使用Janus激酶(JAK)抑制剂后发生的大疱性中心性浆液性脉络膜视网膜病变(CSCR)病例,并描述局灶性激光治疗的结果。评估了一例病例。一名54岁的类风湿性关节炎男性患者,有2周的左上视野缺损病史。他的药物包括泼尼松10mg和乌帕替尼,3周前开始使用该药物。他的视力(VA)右眼为20/25,左眼为20/30。左眼眼科检查发现黄斑区有一个边界不清的白色病变,大小为2×3视盘直径,伴有下方视网膜脱离(RD)。光学相干断层扫描显示视网膜下有纤维蛋白和视网膜下液(SRF)以及色素上皮脱离。在诊断为大疱性CSCR后,进行了局灶性激光治疗。一年后,患者的视力恢复到20/20,视网膜下液消退。伴有浆液性视网膜脱离的大疱性CSCR是厚脉络膜疾病的一种罕见亚型。乌帕替尼可能通过凝血级联失衡与其发生相关。局灶性激光治疗对这种疾病有良好的疗效。